References

1. Popescu, L.M.; Faussone-Pellegrini, M.-S. Telocytes—A case of serendipity: The winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J. Cell. Mol. Med. 2010, 14, 729–740.
2. Pellegrini, M.-S.F.; Popescu, L.M. Telocytes. Biomol. Concepts 2011, 2, 481–489.
3. Cretoiu, D.; Radu, B.M.; Banciu, A.; Banciu, D.D.; Cretoiu, S.M. Telocytes heterogeneity: From cellular morphology to functional evidence. Semin. Cell Dev. Biol. 2017, 64, 26–39.
4. Bei, Y.; Wang, F.; Yang, C.; Xiao, J. Telocytes in regenerative medicine. J. Cell. Mol. Med. 2015, 19, 1441–1454.
5. Chang, Y.; Li, C.; Lu, Z.; Li, H.; Guo, Z. Multiple immunophenotypes of cardiac telocytes. Exp. Cell Res. 2015, 338, 239–244.
6. Cretoiu, S.M.; Popescu, L.M. Telocytes revisited. Biomol. Concepts 2014, 5, 353–369.
7. Lis, G.J.; Dubrowski, A.; Lis, M.; Solewski, B.; Witkowska, K.; Aleksandrovych, V.; Jasek-Gajda, E.; Hołda, M.K.; Gil, K.; Litwin, J.A. Identification of CD34+/PGDFRα+ Valve Interstitial Cells (VICs) in human aortic valves: Association of their abundance, morphology and spatial organization with early calcific remodelling. Int. J. Mol. Sci. 2020, 21, 6330.
8. Vannucchi, M.G.; Traini, C.; Manetti, M.; Ibba-Manneschi, L.; Faussone-Pellegrini, M.S. Telocytes express PDGFRalpha in the human gastrointestinal tract. J. Cell. Mol. Med. 2013, 17, 1099–1108.
9. Xiao, J.; Wang, F.; Liu, Z.; Yang, C. Telocytes in liver: Electron microscopic and immunofluorescent evidence. J. Cell. Mol. Med. 2013, 17, 1537–1542.
10. Xu, Y.; Tian, H.; Cheng, J.; Liang, S.; Li, T.; Liu, J. Immunohistochemical biomarkers and distribution of telocytes in ApoE −/− mice. Cell Biol. Int. 2019, 43, 1286–1295.
11. Zhou, Q.; Wei, L.; Zhong, C.; Fu, S.; Bei, Y.; Huica, R.I.; Wang, F.; Xiao, J. Cardiac telocytes are double positive for CD34/PDGFR-alpha. J. Cell. Mol. Med. 2015, 19, 2036–2042.
12. Bei, Y.; Zhou, Q.; Fu, S.; Lv, D.; Chen, P.; Chen, Y.; Wang, F.; Xiao, J. Cardiac telocytes and fibroblasts in primary culture: Different morphologies and immunophenotypes. PLoS ONE 2015, 10, e0115991.
13. Ceafalan, L.; Gherghiceanu, M.; Popescu, L.M.; Simionescu, O. Telocytes in human skin—Are they involved in skin regeneration? J. Cell. Mol. Med. 2012, 16, 1405–1420.
14. Ciontea, S.M.; Radu, E.; Regalia, T.; Ceafalan, L.C.; Cretoiu, D.; Gherghiceanu, M.; Braga, R.I.; Malincenco, M.; Zagrean, L.; Hinescu, M.E.; et al. C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J. Cell. Mol. Med. 2005, 9, 407–420.
15. Kondo, A.; Kaestner, K.H. Emerging diverse roles of telocytes. Development 2019, 146, 14.
16. Suciu, L.; Popescu, L.M.; Gherghiceanu, M.; Regalia, T.; Nicolescu, M.; Hinescu, M.E.; Faussone-Pellegrini, M.-S. Telocytes in human term placenta: Morphology and phenotype. Cells Tissues Organs 2010, 192, 325–339.
17. Zheng, Y.; Chen, X.; Qian, M.; Zhang, M.; Zhang, D.; Bai, C. Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro mole. Cell. Ther. 2014.
18. Romano, E.; Rosa, I.; Fioretto, B.S.; Lucattelli, E.; Innocenti, M.; Ibba-Manneschi, L.; Matucci-Cerinic, M.; Manetti, M. A Two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells. Int. J. Mol. Sci. 2020, 21, 5877.
19. Bani, D.; Formigli, L.; Gherghiceanu, M.; Faussone-Pellegrini, M.-S. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J. Cell. Mol. Med. 2010, 14, 2531–2538.
20. Cretoiu, D.; Roatesi, S.; Bica, I.; Plesca, C.; Stefan, A.; Bajenaru, O.; Condrat, C.E.; Cretoiu, S.M. Simulation and modeling of telocytes behavior in signaling and intercellular communication processes. Int. J. Mol. Sci. 2020, 21, 2615.
21. Diaz-Flores, L.; Gutiérrez, R.; García, M.P.; González, M.; Madrid, J.F. Telocytes as a source of progenitor cells in regeneration and repair through granulation tissue. Curr. Stem Cell Res. Ther. 2016, 11, 395–403.
22. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; Sáez, F.; Aparicio, F.; Madrid, J.F. Uptake and intracytoplasmic storage of pigmented particles by human CD34+ stromal cells/telocytes: Endocytic property of telocytes. J. Cell. Mol. Med. 2014, 18, 2478–2487.
23. Faussone-Pellegrini, M.-S.; Bani, D. Relationships between telocytes and cardiomyocytes during pre- and post-natal life. J. Cell. Mol. Med. 2010, 14, 1061–1063.
24. Gherghiceanu, M.; Popescu, L.M. Cardiac telocytes—Their junctions and functional implications. Cell Tissue Res. 2012, 348, 265–279.
25. Manetti, M.; Tani, A.; Rosa, I.; Chellini, F.; Squecco, R.; Idrizaj, E.; Zecchi-Orlandini, S.; Ibba-Manneschi, L.; Sassoli, C. Morphological evidence for telocytes as stromal cells supporting satellite cell activation in eccentric contraction-induced skeletal muscle injury. Sci. Rep. 2019, 9, 1–14.
26. Nicolescu, M.; Bucur, A.; Dinca, O.; Rusu, M.; Popescu, L.M. Telocytes in parotid glands. Anat. Rec. Adv. Integr. Anat. Evol. Biol. 2012, 295, 378–385.
27. Popescu, L.M.; Manole, E.; Şerboiu, C.S.; Manole, C.G.; Suciu, L.C.; Gherghiceanu, M.; Popescu, B.O. Identification of telocytes in skeletal muscle interstitium: Implication for muscle regeneration. J. Cell. Mol. Med. 2011, 15, 1379–1392.
28. Vannucchi, M.-G.; Bani, D.; Faussone-Pellegrini, M.-S. Telocytes contribute as cell progenitors and differentiation inductors in tissue regeneration. Curr. Stem Cell Res. Ther. 2016, 11, 383–389.
29. Zhao, B.; Chen, S.; Liu, J.; Yuan, Z.; Qi, X.; Qin, J.; Zheng, X.; Shen, X.; Yu, Y.; Qnin, T.J.; et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J. Cell. Mol. Med. 2012, 17, 123–133.
30. Zheng, Y.; Zhang, M.; Qian, M.; Wang, L.; Cismasiu, V.B.; Bai, C.; Popescu, L.M.; Wang, X. Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts. J. Cell. Mol. Med. 2013, 17, 567–577.
31. Zhou, J.; Wang, Y.; Zhu, P.; Sun, H.; Mou, Y.; Duan, C.; Yao, A.; Lv, S.; Wang, C. Distribution and characteristics of telocytes as nurse cells in the architectural organization of engineered heart tissues. Sci. China Life Sci. 2014, 57, 241–247.
32. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; Gayoso, S.; Gutiérrez, E.; Díaz-Flores, J.L.; Carrasco, J.L. Telocytes in the normal and pathological peripheral nervous system. Int. J. Mol. Sci. 2020, 21, 4320.
33. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; González-Gómez, M.; Carrasco, J.L.; Alvarez-Argüelles, H.; Díaz-Flores, L. Telocytes/CD34+ stromal cells in pathologically affected white adipose tissue. Int. J. Mol. Sci. 2020, 21, 9694.
34. Varga, I.; Polák, Š.; Kyselovič, J.; Kachlík, D.; Danišovič, Ľ.; Klein, M. Recently discovered interstitial cell population of telocytes: Distinguishing facts from fiction regarding their role in the pathogenesis of diverse diseases called “Telocytopathies”. Medicina 2019, 55, 56.
35. Cretoiu, D.; Gherghiceanu, M.; Hummel, E.; Zimmermann, H.; Simionescu, O.; Popescu, L.M. FIB-SEM tomography of human skin telocytes and their extracellular vesicles. J. Cell. Mol. Med. 2015, 19, 714–722.
36. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; Sáez, F.J.; Díaz-Flores, L., Jr.; Valladares, F.; Madrid, J.F. CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells: Location, morphology, function and role in pathology. Histol. Histopathol. 2014, 29, 831–870.
37. Manole, C.G.; Simionescu, O. The cutaneous telocytes. Adv. Exp. Med. Biol. 2016, 913, 303–323.
38. Manetti, M.; Guiducci, S.; Ruffo, M.; Rosa, I.; Faussone-Pellegrini, M.S.; Matucci-Cerinic, M.; Ibba-Manneschi, L. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J. Cell. Mol. Med. 2013, 17, 482–496.
39. Crețoiu, S. Telocytes and other interstitial cells: From structure to function. Int. J. Mol. Sci. 2021, 22, 5271.
40. Rusu, M.; Mirancea, N.; Mănoiu, V.; Vâlcu, M.; Nicolescu, M.; Păduraru, D. Skin telocytes. Ann. Anat. Anat. Anz. 2012, 194, 359–367.
41. Wang, L.; Xiao, L.; Zhang, R.; Jin, H.; Shi, H. Ultrastructural and immunohistochemical characteristics of telocytes in human scalp tissue. Sci. Rep. 2020, 10, 1–7.
42. Arafat, E.A. Ultrastructural and immunohistochemical characteristics of telocytes in the skin and skeletal muscle of newborn rats. Acta Histochem. 2016, 118, 574–580.
43. Kang, Y.; Zhu, Z.; Zheng, Y.; Wan, W.; Manole, C.G.; Zhang, Q. Skin telocytes versus fibroblasts: Two distinct dermal cell populations. J. Cell. Mol. Med. 2015, 19, 2530–2539.
44. Zhou, Y.; Yang, Y.; Liang, T.; Hu, Y.; Tang, H.; Song, D.; Fang, H. The regulatory effect of microRNA-21a-3p on the promotion of telocyte angiogenesis mediated by PI3K (p110α)/AKT/mTOR in LPS induced mice ARDS. J. Transl. Med. 2019, 17, 1–27.
45. Wang, L.; Song, D.; Wei, C.; Chen, C.; Yang, Y.; Deng, X.; Gu, J. Telocytes inhibited inflammatory factor expression and enhanced cell migration in LPS-induced skin wound healing models in vitro and in vivo. J. Transl. Med. 2020, 18, 60.
46. Brinster, N.; Liu, V.; Diwan, H.; McKee, P. Dermatopathology. High.-Yield Pathology, 1st ed.; Saunders: Philadelphia, PA, USA, 2011; ISBN 978-1-4160-9976-5.
47. Manetti, M.; Rosa, I.; Messerini, L.; Guiducci, S.; Matucci-Cerinic, M.; Ibba-Manneschi, L. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J. Cell. Mol. Med. 2014, 18, 253–262.
48. Ibba-Manneschi, L.; Rosa, I.; Manetti, M. Telocytes in chronic inflammatory and fibrotic diseases. Adv. Exp. Med. Biol. 2016, 913, 51–76.
49. Manole, C.; Gherghiceanu, M.; Simionescu, O. Telocyte dynamics in psoriasis. J. Cell. Mol. Med. 2015, 19, 1504–1519.
50. Mirancea, N.; Moroşanu, A.-M.; Mirancea, G.-V.; Juravle, F.D.; Mănoiu, V.S. Infrastructure of the telocytes from tumor stroma in the skin basal and squamous cell carcinomas. Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol. 2013, 54, 1025–1037.
51. Braverman, I.M. The cutaneous microcirculation. J. Investig. Dermatol. Symp. Proc. 2000, 5, 3–9.
52. Roustit, M.; Cracowski, J.-L. Non-invasive assessment of skin microvascular function in humans: An insight into methods. Microcirculation 2011, 19, 47–64.
53. Deegan, A.J.; Wang, R.K. Microvascular imaging of the skin. Phys. Med. Biol. 2019, 64, 07TR01.
54. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; González-Gómez, M.; Álvarez-Argüelles, H.; Carrasco, J.L. Presence/absence and specific location of resident CD34+ stromal cells/telocytes condition stromal cell development in repair and tumors. Front. Cell Dev. Biol. 2020, 8, 544845.
55. Wang, B.; Liu, X.-M.; Liu, Z.-N.; Wang, Y.; Han, X.; Lian, A.-B.; Mu, Y.; Jin, M.-H.; Liu, J.-Y. Human hair follicle-derived mesenchymal stem cells: Isolation, expansion, and differentiation. World J. Stem Cells 2020, 12, 462–470.
56. Romano, E.; Rosa, I.; Fioretto, B.S.; Cerinic, M.M.; Manetti, M. The role of pro-fibrotic myofibroblasts in systemic sclerosis: From origin to therapeutic targeting. Curr. Mol. Med. 2021, 21, 1.
57. Rosa, I.; Romano, E.; Fioretto, B.S.; Matucci-Cerinic, M.; Manetti, M. Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis. World J. Stem Cells 2021, 13, 30–48.
58. Manetti, M. Correspondence on ‘Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement’. Ann. Rheum. Dis. 2020.
59. Rosa, I.; Romano, E.; Fioretto, B.S.; Manetti, M. The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis. Eur. J. Rheumatol. 2020, 7, 157–164.
60. Manetti, M. Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis? Ann. Rheum. Dis. 2019, 79, e55.
61. Chora, I.; Romano, E.; Manetti, M.; Mazzotta, C.; Costa, R.; Machado, A.; Cortez, A.; Bruni, C.; Lepri, G.; Guiducci, S.; et al. Evidence for a derangement of the microvascular system in patients with a very early diagnosis of systemic sclerosis. J. Rheumatol. 2017, 44, 1190–1197.
62. Johnson, W.C.; Graham, J.H.; Helwig, E.B. Cutaneous myxoid cyst. JAMA 1965, 191, 15–20.
63. Díaz-Flores, L.; Gutiérrez, R.; García, M.D.P.; Álvarez-Argüelles, H.; López-Campos, D. CD34-positive fibroblasts in Reinke’s edema. Laryngoscope 2013, 124, E73–E80.
64. Domínguez-Malagón, H.R.; Ordòñez, N.G.; Mackay, B. Dermatofibrosarcoma protuberans: Ultrastructural and immunocytochemical observations. Ultrastruct. Pathol. 1995, 19, 281–289.
65. Hao, X.; Billings, S.D.; Wu, F.; Stultz, T.W.; Procop, G.W.; Mirkin, G.; Vidimos, A.T. Dermatofibrosarcoma protuberans: Update on the diagnosis and treatment. J. Clin. Med. 2020, 9, 1752.
66. Song, J.S.; Kim, E.-J.; Park, C.-S.; Cho, K.-J. Dermatofibrosarcoma protuberans: An immunomarker study of 57 Cases that included putative mesenchymal stem cell markers. Appl. Immunohistochem. Mol. Morphol. 2017, 25, 586–591.
67. Rapini, R.P.; Golitz, L.E. Sclerotic fibromas of the skin. J. Am. Acad. Dermatol. 1989, 20, 266–271.
68. Hanft, V.N.; Shea, C.R.; McNutt, N.S.; Pullitzer, D.; Horenstein, M.G.; Prieto, V.G. Expression of CD34 in sclerotic (“plywood”) fibromas. Am. J. Dermatopathol. 2000, 22, 17–21.
69. Westra, W.H.; Gerald, W.L.; Rosai, J. Solitary fibrous tumor consistent CD34 immunoreactivity and occurrence in the orbit. Am. J. Surg. Pathol. 1994, 18, 992–998.
70. Sakai, Y.; Matsukuma, S. CD34+ stromal cells and hyalinized vascular changes in the anal fibroepithelial polyps. Histopathology 2002, 41, 230–235.
71. Shaaban, A.M.; Turton, E.; Merchant, W. An unusual case of a large fibroepithelial stromal polyp presenting as a nipple mass. BMC Res. Notes 2013, 6, 345.
72. Smith, S.C.; Poznanski, A.A.; Fullen, D.R.; Ma, L.; McHugh, J.B.; Lucas, D.R.; Patel, R.M. CD34-positive superficial myxofibrosarcoma: A potential diagnostic pitfall. J. Cutan. Pathol. 2013, 40, 639–645.
73. Diaz-Flores, L.; Gutiérrez, R.; Lizartza, K.; Goméz, M.G.; García, M.D.P.; Sáez, F.J.; Madrid, J.F. Behavior of in situ human native adipose tissue CD34+ stromal/progenitor cells during different stages of repair: Tissue-resident CD34+ stromal cells as a source of myofibroblasts. Anat. Rec. Adv. Integr. Anat. Evol. Biol. 2015, 298, 917–930.
74. Kirchmann, T.T.; Prieto, V.G.; Smoller, B.R. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch. Dermatol. 1994, 130, 589–592.
75. Sengul, D.M.; Sengul, I.; Astarci, M.H.; Ustun, H.; Mocan, G. Differential diagnosis of basal cell carcinoma and benign tumors of cutaneous appendages originating from hair follicles by using CD. Asian Pac. J. Cancer Prev. 2010, 11, 1615–1619.
76. Tebcherani, A.J.; De Andrade, J.H.F.; Sotto, M.N. Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: Evaluation using tissue microarray samples. Mod. Pathol. 2012, 25, 1345–1353.
77. Patel, P.; Hussain, K. Merkel cell carcinoma. Clin. Exp. Dermatol. 2021, 46, 814–819.
78. Wessel, C.; Westhoff, C.C.; Nowak, K.; Moll, I.; Barth, P.J. CD34+ fibrocytes in melanocytic nevi and malignant melanomas of the skin. Virchows Arch. 2008, 453, 485–489.
79. Fernandes, N.R.J.; Reilly, N.S.; Schrock, D.C.; Hocking, D.C.; Oakes, P.; Fowell, D.J. CD4+ T cell interstitial migration controlled by fibronectin in the inflamed skin. Front. Immunol. 2020, 11, 1501.
80. Gaylo, A.; Overstreet, M.G.; Fowell, D.J. Imaging CD4 T cell interstitial migration in the inflamed dermis. J. Vis. Exp. 2016, 109, e53585.
81. Gaylo, A.; Schrock, D.C.; Fernandes, N.R.J.; Fowell, D.J. T cell interstitial migration: Motility cues from the inflamed tissue for micro- and macro-positioning. Front. Immunol. 2016, 7, 428.